CircRNA Synthesis Market By Product & Service (Reagents & Kits, Instruments, Services); By Application (Therapeutics Development, Drug Discovery, Other Applications); By End Use (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Others); By Region – Growth, Share, Opportunities & Competitive Analysis, 2025 – 2032
The global CircRNA Synthesis Market size was estimated at USD 189.75 million in 2025 and is expected to reach USD 527 million by 2032, growing at a CAGR of 15.7% from 2025 to 2032, following the required structure in your prompt file. The strongest growth driver is the accelerating adoption of circular RNA constructs in advanced therapeutics programs, where improved RNA stability and sustained expression profiles increase demand for reliable synthesis workflows across discovery and development. CircRNA Synthesis Market expansion is also supported by broader RNA platform investments across established biopharma and emerging biotech ecosystems.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2024
Base Year
2025
Forecast Period
2026-2032
CircRNA Synthesis Market Size 2025
USD 189.75 million
CircRNA Synthesis Market, CAGR
15.7%
CircRNA Synthesis Market Size 2032
USD 527 million
Key Market Trends & Insights
CircRNA Synthesis Market is projected to expand from USD 189.75 million in 2025 to USD 527 million by 2032, reflecting a 15.7% CAGR over 2025–2032.
North America accounted for the largest regional share of 42.8% in 2025, reflecting concentration of RNA-therapy R&D and commercial procurement in the region.
Reagents & Kits accounted for the largest share of 44.6% in 2025, supported by recurring consumable demand across circularization, purification, and QC workflows.
Therapeutics Development held the largest application share of 61.2% in 2025, driven by expanding use of circRNA constructs for vaccine, oncology, and rare-disease research pipelines.
Pharmaceutical and Biotechnology Companies represented the largest end-use share of 56.8% in 2025, reflecting higher spend intensity and outsourcing requirements for complex synthesis.
Segment Analysis
CircRNA Synthesis Market demand is shaped by two procurement patterns: high-frequency purchases of workflow-critical consumables and an increasing preference for outsourcing specialized steps. Reagents and kits remain central because circRNA synthesis requires multiple steps such as template preparation, circularization, purification, and verification, and each step drives repeat consumption. Instruments contribute through analytical validation and process standardization, especially where buyers aim to improve reproducibility and documentation.
Application demand is anchored in therapeutics development, where circRNA stability and potential for longer-lived expression support use in next-generation RNA modalities. Drug discovery demand is supported by broader exploratory use of synthetic circRNAs for target validation and screening models, especially when programs require rapid design iterations. Other applications include method development, academic hypothesis testing, and platform benchmarking.
End-use trends indicate biopharma buyers increasingly pursue integrated offerings that combine design support, synthesis execution, purification, and quality checks. Academic and research institutes expand adoption as tools become more accessible and as collaborations with biotech translate basic research into preclinical programs. Other end users participate through translational research, platform services, and early-stage proof-of-concept projects.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
Reagents & Kits accounted for the largest share of 44.6% in 2025. Reagents & Kits lead because circRNA synthesis workflows require consistent enzymes, buffers, circularization reagents, and purification inputs across repeated experimental cycles. Reagents & Kits also benefit from standardized protocols that improve reproducibility across labs and reduce batch-to-batch variability concerns. Service providers frequently bundle proprietary consumables into service delivery, which further sustains reagent demand alongside outsourcing growth.
By Application Insights
Therapeutics Development accounted for the largest share of 61.2% in 2025. Therapeutics Development leads because circRNA constructs are evaluated for improved stability and sustained protein expression, which aligns with therapeutic modality needs across multiple disease areas. Therapeutics Development programs also demand higher-quality synthesis and tighter quality controls, which increases spend per project relative to exploratory work. Therapeutics Development activity is reinforced by platform-level investments where circRNA is assessed alongside other RNA formats for performance and manufacturability.
By End Use Insights
Pharmaceutical and Biotechnology Companies accounted for the largest share of 56.8% in 2025. Pharmaceutical and Biotechnology Companies lead because pipeline programs require scalable synthesis, consistent characterization, and rapid iteration across multiple constructs and indications. Pharmaceutical and Biotechnology Companies also adopt outsourcing models to access specialized expertise for circularization, purification, and quality verification steps. Pharmaceutical and Biotechnology Companies typically maintain higher procurement budgets and prioritize standardized documentation, which increases demand for validated workflows and supplier reliability.
CircRNA Synthesis Market Drivers
Expansion of RNA therapeutics pipelines and platform diversification
CircRNA Synthesis Market growth is supported by expanding RNA-based therapeutic pipelines that include exploration of circular RNA for stability and sustained expression advantages. CircRNA Synthesis Market adoption rises when therapeutic programs require multiple construct iterations, rapid turnaround, and reproducible synthesis outcomes. CircRNA Synthesis Market demand also benefits from platform diversification trends in which developers evaluate multiple RNA formats to optimize performance for different indications. CircRNA Synthesis Market purchasing increases as programs move from feasibility studies into preclinical development with higher quality expectations.
For instance, Orna Therapeutics screened thousands of IRES elements across multiple primary human cell types using its FoRCE platform, ultimately enabling its lead oRNA program ORN-101 to achieve tumor eradication in mouse models at 10–20-fold lower doses than earlier construct versions demonstrating how iterative construct diversification across multiple RNA formats directly drives demand for high-throughput, reproducible synthesis capacity.
Increasing outsourcing of complex synthesis and characterization steps
CircRNA Synthesis Market demand strengthens as buyers outsource specialized workflow steps such as circularization optimization, purification strategy selection, and verification testing. CircRNA Synthesis Market service uptake is reinforced by the need to shorten timelines and reduce internal method-development burden. CircRNA Synthesis Market suppliers that provide integrated design-to-QC offerings reduce operational friction for customers managing multiple candidates. CircRNA Synthesis Market growth is further supported when outsourcing converts fixed costs into variable costs aligned to pipeline milestones.
Rising need for standardized, reproducible workflows across research settings
CircRNA Synthesis Market expansion is driven by the need for standardized and reproducible workflows across labs, particularly where programs require cross-site comparability. CircRNA Synthesis Market buyers prioritize kits and validated processes that reduce variability across runs and improve experimental confidence. CircRNA Synthesis Market instrument utilization supports documentation and validation of synthesis outcomes through analytical confirmation steps. CircRNA Synthesis Market procurement strengthens as organizations formalize quality procedures and strengthen traceability requirements.
Greater accessibility of synthesis toolkits and vendor ecosystems
CircRNA Synthesis Market growth is enabled by broader availability of commercial toolkits, catalog reagents, and customizable service menus that simplify adoption. CircRNA Synthesis Market demand increases when suppliers lower technical barriers through protocols, troubleshooting support, and modular workflow options. CircRNA Synthesis Market expansion is supported by vendor ecosystems that combine materials, instruments, and services for end-to-end execution. CircRNA Synthesis Market adoption accelerates as more buyers gain confidence that circRNA synthesis can be implemented without extensive in-house specialization.
For instance, GenScript structured its circRNA synthesis offering as a modular service menu with off-the-shelf construct options for fast delivery, insert sequence lengths from 100 bp to 4 kb, and batch scales from 200 µg to 10 mg with entry-level pricing starting at $800 per 25 µg allowing academic labs and early-stage biotechs to access functional circRNA without developing internal IVT or HPLC purification capability.
CircRNA Synthesis Market Challenges
CircRNA Synthesis Market faces technical challenges related to achieving consistent circularization efficiency, minimizing impurities, and validating product integrity across different sequence designs. CircRNA Synthesis Market buyers often encounter variability risks when scaling from exploratory synthesis to more controlled workflows, which can increase repeat work and costs. CircRNA Synthesis Market complexity also increases when workflows must be adapted for different constructs, as optimization requirements can be sequence-specific. CircRNA Synthesis Market growth can be constrained when teams lack experienced staff to design robust protocols and interpret characterization results.
For instance, TRIC-V2 circularization experiments showed that extending stem length from 5 bp (V1.0) to 25 bp raised circularization efficiency to 97.8% at 8 minutes with a yield of 74.8%, yet further extending the external guide sequence beyond 40 nucleotides produced no measurable gain demonstrating that each nucleotide-level design decision can have non-linear effects on outcome, requiring re-optimization per construct.
CircRNA Synthesis Market also experiences operational and procurement constraints tied to quality expectations and supply continuity for specialized reagents. CircRNA Synthesis Market projects can face delays when lead times for critical enzymes, purification materials, or verification tools increase. CircRNA Synthesis Market adoption in smaller labs can be limited by budget constraints, particularly when workflows require both consumables and instruments. CircRNA Synthesis Market suppliers must balance customization needs with standardized delivery models, which can pressure margins and delivery timelines.
CircRNA Synthesis Market Trends and Opportunities
CircRNA Synthesis Market trends indicate rising demand for integrated offerings that combine construct design guidance, synthesis execution, purification, and verification within a single vendor workflow. CircRNA Synthesis Market customers increasingly prefer partners that can support iterative design cycles and provide consistent documentation for internal reviews. CircRNA Synthesis Market opportunity expands as service models mature and as buyers seek predictable turnaround times across multiple projects. CircRNA Synthesis Market suppliers can differentiate through standardized QC packages and scalable production options aligned to development stages.
For instance, GenScript offers custom circRNA synthesis for insert sequences from 100 bp to 4 kb with delivery in 3 weeks, and the company reports typical circularization efficiency of 60% to 90% along with HPLC purification yields of around 20% to 40%.
CircRNA Synthesis Market opportunity is also supported by expanding adoption beyond early research into more structured preclinical workflows where repeatability and traceability become central. CircRNA Synthesis Market vendors can expand by offering modular product bundles that match buyer maturity, from entry-level kits to advanced purification and analytics support. CircRNA Synthesis Market growth can benefit from education-led commercialization such as protocols, training, and application notes that reduce adoption friction. CircRNA Synthesis Market regional opportunity strengthens as Asia Pacific ecosystems expand and as collaboration networks increase cross-border demand.
Regional Insights
North America
North America held a 42.8% share of CircRNA Synthesis Market revenue in 2025. North America demand is supported by higher concentration of RNA-therapeutics programs, established procurement budgets, and strong adoption of outsourcing for specialized synthesis steps. North America also benefits from dense supplier ecosystems that support faster iteration cycles and service availability.
Europe
Europe accounted for 31.9% of CircRNA Synthesis Market revenue in 2025. Europe demand is supported by strong academic research bases and established biopharma clusters that sustain both consumable purchases and service utilization. Europe also shows structured adoption through collaborations that translate early research into applied development programs.
Asia Pacific
Asia Pacific represented 23.6% of CircRNA Synthesis Market revenue in 2025. Asia Pacific growth is supported by expanding biotechnology ecosystems, increasing R&D intensity, and rising demand for accessible synthesis toolkits and scalable service options. Asia Pacific also benefits from growing cross-border collaborations and increased investment in RNA platform technologies.
Latin America
Latin America accounted for 1.1% of CircRNA Synthesis Market revenue in 2025. Latin America adoption remains early-stage, with demand concentrated in selected research hubs where RNA and advanced therapeutics activity is expanding. Latin America opportunity is linked to improving research infrastructure and broader access to outsourced synthesis services.
Middle East & Africa
Middle East and Africa accounted for 0.6% of CircRNA Synthesis Market revenue in 2025. Middle East and Africa activity remains nascent, with adoption primarily linked to specialized research centers and emerging innovation programs. Middle East and Africa growth potential depends on expanding translational research capacity and procurement accessibility.
Competitive Landscape
CircRNA Synthesis Market competition includes a mix of catalog reagent suppliers, custom synthesis specialists, and multi-omics service platforms that compete on turnaround time, synthesis reliability, and documentation quality. CircRNA Synthesis Market differentiation is increasingly shaped by end-to-end workflow coverage, where vendors bundle design support, circularization optimization, purification, and verification. CircRNA Synthesis Market participants also compete through breadth of catalog offerings and the ability to support both discovery-scale and more controlled development-stage requirements. CircRNA Synthesis Market buyers commonly evaluate vendors on reproducibility, technical support depth, and capability to customize workflows for different constructs.
GenScript is positioned as a prominent provider across research tools and custom services that can support RNA-adjacent workflows through synthesis capabilities, workflow guidance, and standardized delivery processes. GenScript can benefit from cross-selling opportunities where customers procure reagents and services together to reduce workflow fragmentation. GenScript differentiation typically centers on service execution capability and the ability to support multiple stages of R&D from exploratory work through more structured development needs. GenScript also competes by offering technical support and process standardization that reduces adoption friction for complex synthesis workflows.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In December 2025, uBriGene Biosciences and Circurna announced a strategic partnership to accelerate the development and manufacturing of circular RNA/LNP therapeutics. In this collaboration, uBriGene agreed to support process and analytical development, scale-up, and GMP production, while Circurna contributes its proprietary circRNA platform to move programs toward the clinic.
In June 2025, Circio Holding ASA and NeoRegen Biotech expanded their ongoing partnership by signing a second Material Transfer Agreement to move their circular RNA delivery collaboration into the in vivo preclinical stage. The update centers on combining Circio’s circVec expression platform with NeoRegen’s NICT delivery technology to validate targeted and durable intracellular delivery for future therapeutic development.
In May 2025, Altamira Therapeutics announced a collaboration agreement with an undisclosed partner to evaluate its CycloPhore platform for delivering circular RNA payloads. The company said the project will test the platform in vitro and in vivo, and the partner may later negotiate a licensing agreement to develop and commercialize circRNA nanoparticles.
Report Scope
Report Attribute
Details
Market size value in 2025
USD 189.75 million
Revenue forecast in 2032
USD 527 million
Growth rate (CAGR)
15.7% (2025–2032)
Base year
2025
Forecast period
2026–2032
Quantitative units
USD million
Segments covered
By Product & Service Outlook: Reagents & Kits, Instruments, Services; By Application Outlook: Therapeutics Development, Drug Discovery, Other Applications; By End Use Outlook: Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Others
Regional scope
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Market Breakup by End Use
8.1. Pharmaceutical and Biotechnology Companies
8.1.1. Market Trends
8.1.2. Market Forecast
8.1.3. Revenue Share
8.1.4. Revenue Growth Opportunity
8.2. Academic and Research Institutes
8.2.1. Market Trends
8.2.2. Market Forecast
8.2.3. Revenue Share
8.2.4. Revenue Growth Opportunity
8.3. Others
8.3.1. Market Trends
8.3.2. Market Forecast
8.3.3. Revenue Share
8.3.4. Revenue Growth Opportunity
Market Breakup by Region
9.1. North America
9.1.1. United States
9.1.1.1. Market Trends
9.1.1.2. Market Forecast
9.1.2. Canada
9.1.2.1. Market Trends
9.1.2.2. Market Forecast
9.2. Asia-Pacific
9.2.1. China
9.2.2. Japan
9.2.3. India
9.2.4. South Korea
9.2.5. Australia
9.2.6. Indonesia
9.2.7. Others
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. United Kingdom
9.3.4. Italy
9.3.5. Spain
9.3.6. Russia
9.3.7. Others
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Others
9.5. Middle East and Africa
9.5.1. Market Trends
9.5.2. Market Breakup by Country
9.5.3. Market Forecast
Porters Five Forces Analysis
12.1. Overview
12.2. Bargaining Power of Buyers
12.3. Bargaining Power of Suppliers
12.4. Degree of Competition
12.5. Threat of New Entrants
12.6. Threat of Substitutes
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions:
What is the market size and forecast for the CircRNA Synthesis Market?
CircRNA Synthesis Market was valued at USD 189.75 million in 2025. CircRNA Synthesis Market is projected to reach USD 527 million by 2032.
What is the CAGR for the CircRNA Synthesis Market?
CircRNA Synthesis Market is expected to grow at 15.7% CAGR. The growth period is 2025–2032.
What is the largest segment in the CircRNA Synthesis Market?
Reagents & Kits is the leading segment by Product & Service with 44.6% share in 2025. Therapeutics Development leads By Application with 61.2% share in 2025.
What are the key growth factors for the CircRNA Synthesis Market?
CircRNA Synthesis Market growth is driven by expanding RNA therapeutics pipelines and platform diversification. CircRNA Synthesis Market adoption also increases with greater outsourcing and standardized workflow demand.
Which companies are profiled in the CircRNA Synthesis Market?
Key companies include GenScript, Azenta / GENEWIZ, Thermo Fisher Scientific, VectorBuilder, and LGC Biosearch Technologies. Additional profiled companies include Creative Biogene, Creative Biolabs, GeneCopoeia, BOC Sciences, and others listed in the scope.
Which region leads the CircRNA Synthesis Market?
North America leads the CircRNA Synthesis Market with a 42.8% share in 2025. Europe follows with a 31.9% share in 2025
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
The global Complex Injectables Market size was estimated at USD 26,141 million in 2025 and is expected to reach USD 46,572 million by 2032, growing at a CAGR of 8.6% from 2025 to 2032.
The global Cardiovascular Drugs Market size was estimated at USD 157,413 million in 2025 and is expected to reach USD 212,787 million by 2032, growing at a CAGR of 4.4% from 2025 to 2032.
The global Chronic Obstructive Pulmonary Disease Drugs Market size was estimated at USD 8389 million in 2025 and is expected to reach USD 12448 million by 2032, growing at a CAGR of 5.8% from 2025 to 2032.
The global CDKL5 Deficiency Disorder Market size was estimated at USD 121 million in 2025 and is expected to reach USD 169 million by 2032, growing at a CAGR of 4.89% from 2025 to 2032.
The global Cervical Cancer Diagnostics And Therapeutics Market size was estimated at USD 117,657 million in 2025 and is expected to reach USD 177,029 million by 2032, growing at a CAGR of 6.01% from 2025 to 2032.
The global chronic lymphocytic leukemia market size was estimated at USD 5,379 million in 2025 and is expected to reach USD 8,304 million by 2032, growing at a CAGR of 6.4% from 2025 to 2032
The global Castrate Resistant Prostate Cancer Therapeutics Market size was estimated at USD 14005 million in 2025 and is expected to reach USD 24791.16 million by 2032, growing at a CAGR of 8.5% from 2025 to 2032.
The global Cell And Gene Therapy Contract Development And Manufacturing Organization Market size was estimated at USD 8044 million in 2025 and is expected to reach USD 44593.74 million by 2032, growing at a CAGR of 27.72% from 2025 to 2032.
The global Cell Based Immunotherapy Market size was estimated at USD 4,953 million in 2025 and is expected to reach USD 12,114.69 million by 2032, growing at a CAGR of 13.63% from 2025 to 2032.
The global Cardiac Arrhythmia Therapeutics Market size was estimated at USD 7478 million in 2025 and is expected to reach USD 11658.96 million by 2032, growing at a CAGR of 6.55% from 2025 to 2032.
The global Capecitabine Market size was estimated at USD 1177 million in 2025 and is expected to reach USD 1689.45 million by 2032, growing at a CAGR of 5.3% from 2025 to 2032.
The global Calcineurin Inhibitors Market size was estimated at USD 12,740 million in 2025 and is expected to reach USD 23,289.07 million by 2032, growing at a CAGR of 9% from 2025 to 2032.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$3999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$4999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
